ACTIVE

OOSTVELD - PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

135,3 k €

-3.6% YoY

Gross margin

393,5 k €

+3.3% YoY

Equity

555 k €

0.0% YoY

Workforce

1,9 ETP

0.0% YoY

What does OOSTVELD - PHARMA do?

OOSTVELD - PHARMA is a Private limited company incorporated in 2001. Its registered office is in Lievegem. It employs on average 1,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0476.087.480

Incorporation

15/11/2001

Legal form

Private limited company

Registered office

Oostveld Kouter 171
9920 Lievegem · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Average workforce

1,9 ETP

Joint committees (2)

313
3130

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	393,5 k €	+3.3%	380,9 k €	+14.5%	332,7 k €	+11.0%	299,7 k €	+19.9%	249,8 k €	+13.8%	219,5 k €	-7.8%	238 k €	-8.9%	261,4 k €	-0.8%	263,4 k €	+7.9%	244,1 k €	-5.4%	258,1 k €	-4.8%	271,1 k €	+1.3%	267,7 k €	-1.0%	270,4 k €	+2.1%	264,8 k €	+6.4%	248,8 k €	+2.0%	244 k €	+19.1%	204,9 k €
EBITDA	248,7 k €	-4.4%	260,3 k €	+26.9%	205,1 k €	+4.2%	196,8 k €	+22.8%	160,3 k €	+16.8%	137,2 k €	-16.4%	164,1 k €	-12.0%	186,4 k €	+5.1%	177,5 k €	+7.3%	165,4 k €	-11.0%	185,9 k €	-2.8%	191,2 k €	-0.8%	192,8 k €	-10.1%	214,4 k €	+0.6%	213,2 k €	+8.4%	196,7 k €	+2.4%	192 k €	+22.0%	157,4 k €
Operating result	177,5 k €	-4.2%	185,2 k €	+36.9%	135,3 k €	+2.3%	132,2 k €	+41.4%	93,5 k €	-26.4%	127 k €	-17.2%	153,4 k €	-13.6%	177,5 k €	+5.6%	168,2 k €	+2.2%	164,5 k €	-10.2%	183,1 k €	-3.0%	188,8 k €	+25.9%	150 k €	-11.4%	169,3 k €	+0.8%	167,9 k €	+10.0%	152,6 k €	+2.6%	148,6 k €	+26.4%	117,6 k €
Net result	135,3 k €	-3.6%	140,4 k €	+36.9%	102,6 k €	-5.7%	108,8 k €	-50.2%	218,5 k €	+112%	103,3 k €	-12.5%	118 k €	-13.1%	135,8 k €	+3.1%	131,7 k €	+0.4%	131,1 k €	-12.1%	149,2 k €	-0.4%	149,9 k €	+12.1%	133,7 k €	+1.7%	131,5 k €	+11.3%	118,2 k €	+9.8%	107,6 k €	+26.5%	85,1 k €	+11.1%	76,6 k €
Balance sheet
Equity	555 k €	0.0%	555 k €	0.0%	555 k €	0.0%	555 k €	0.0%	555 k €	+0.7%	551,4 k €	0.0%	551,4 k €	-1.4%	559,4 k €	+0.1%	558,6 k €	-0.6%	561,9 k €	-3.2%	580,8 k €	-2.6%	596,5 k €	-0.4%	598,7 k €	-2.7%	615 k €	+11.6%	551 k €	+24.3%	443,4 k €	+32.0%	335,8 k €	+33.9%	250,7 k €
Total assets	1,3 M €	-3.1%	1,3 M €	-1.0%	1,3 M €	-7.4%	1,4 M €	-6.9%	1,5 M €	+101%	755,9 k €	-4.0%	787,2 k €	-2.3%	806 k €	-2.3%	825,2 k €	-1.1%	834,6 k €	+0.9%	827,3 k €	+0.6%	822,7 k €	+1.6%	809,7 k €	+8.8%	743,9 k €	+19.6%	622 k €	+17.2%	530,8 k €	+12.0%	474 k €	-13.4%	547,5 k €
Cash	113,4 k €	+1.2%	112,1 k €	+38.2%	81,1 k €	+17.7%	68,9 k €	-22.0%	88,3 k €	+44.4%	61,2 k €	-22.3%	78,7 k €	-1.7%	80,1 k €	-0.6%	80,6 k €	-0.5%	81 k €	-15.5%	95,9 k €	+13.1%	84,8 k €	-15.9%	100,8 k €	-13.7%	116,8 k €	-66.1%	345,1 k €	+183%	122 k €	-8.9%	133,9 k €	-24.9%	178,2 k €
Debts	702,1 k €	-5.5%	743 k €	-1.8%	756,6 k €	-12.2%	862,1 k €	-10.8%	966,9 k €	+373%	204,5 k €	-13.3%	235,8 k €	-4.4%	246,6 k €	-7.5%	266,6 k €	-2.2%	272,7 k €	+10.6%	246,5 k €	+9.0%	226,2 k €	+7.2%	211 k €	+63.7%	128,9 k €	+84.4%	69,9 k €	-16.1%	83,3 k €	-35.2%	128,5 k €	-54.7%	283,4 k €
Other
Workforce	1,9 ETP	0.0%	1,9 ETP	+11.8%	1,7 ETP	+6.2%	1,6 ETP	+6.7%	1,5 ETP	-6.3%	1,6 ETP	+23.1%	1,3 ETP	-18.8%	1,6 ETP	-15.8%	1,9 ETP	+5.6%	1,8 ETP	+38.5%	1,3 ETP	-13.3%	1,5 ETP	-16.7%	1,8 ETP	+28.6%	1,4 ETP	+16.7%	1,2 ETP	+20.0%	1,0 ETP	0.0%	1,0 ETP	-9.1%	1,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 9 ended

Active mandates

CILODA

Director · since 01 juillet 2018 · 0820.384.131

Represented by Locy David

Active

Cindy Van Dycke

Director · since 01 janvier 2010

Active

Ended mandates

CILODA

Manager · since 01 juillet 2010 · 0820.384.131

Represented by Van Dycke cindy

Ended

CILODA

Manager · since 01 juillet 2010 · 0820.384.131

Represented by VAN DYCKE CINDY

Ended

Cindy Van Dycke

Manager · since 01 janvier 2010

Ended

Dycke Cindy Van

Director · since 01 janvier 2010

Ended

At this address

Other companies at this address

Company	CBE no.
CILODA● Active	0820.384.131

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	24/06/2026	17/06/2025	03/06/2024	05/07/2023	21/06/2022	25/06/2021
General meeting	27/05/2026	28/05/2025	29/05/2024	21/06/2023	25/05/2022	26/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	27/05/2026	24/06/2026	Dutch	PDF
Abridged model	31/12/2024	28/05/2025	17/06/2025	Dutch	PDF
Abridged model	31/12/2023	29/05/2024	03/06/2024	Dutch	PDF
Abridged model	31/12/2022	21/06/2023	05/07/2023	Dutch	PDF
Abridged model	31/12/2021	25/05/2022	21/06/2022	Dutch	PDF
Abridged model	31/12/2020	26/05/2021	25/06/2021	Dutch	PDF
Abridged model	31/12/2019	17/06/2020	16/07/2020	Dutch	PDF
Abridged model	31/12/2018	29/05/2019	03/06/2019	Dutch	PDF
Abridged model	31/12/2017	30/05/2018	03/07/2018	Dutch	PDF
Abridged model	31/12/2016	31/05/2017	30/06/2017	Dutch	PDF
Abridged model	31/12/2015	25/05/2016	24/06/2016	Dutch	PDF
Abridged model	31/12/2014	27/05/2015	25/06/2015	Dutch	PDF
Abridged model	31/12/2013	28/05/2014	25/06/2014	Dutch	PDF
Abridged model	31/12/2012	29/05/2013	24/06/2013	Dutch	PDF
Abridged model	31/12/2011	22/06/2012	20/07/2012	Dutch	PDF
Abridged model	31/12/2010	25/05/2011	23/06/2011	Dutch	PDF
Abridged model	31/12/2009	26/05/2010	25/06/2010	Dutch	PDF
Abridged model	31/12/2008	27/05/2009	22/06/2009	Dutch	PDF
Abridged model	31/12/2007	28/05/2008	26/06/2008	Dutch	PDF
Abridged model	31/12/2006	30/06/2007	31/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 9 ended

Active mandates

CILODA

Director · since 01 juillet 2018 · 0820.384.131

Represented by Locy David

Active

Cindy Van Dycke

Director · since 01 janvier 2010

Active

Ended mandates

CILODA

Manager · since 01 juillet 2010 · 0820.384.131

Represented by Van Dycke cindy

Ended

CILODA

Manager · since 01 juillet 2010 · 0820.384.131

Represented by VAN DYCKE CINDY

Ended

Cindy Van Dycke

Manager · since 01 janvier 2010

Ended

Dycke Cindy Van

Director · since 01 janvier 2010

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates01/08/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/05/2020
ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Mandates06/09/2010
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/02/2010
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025135,3 k €↓
2024
Annual accounts 2024140,4 k €↑
2023
Annual accounts 2023102,6 k €↓
2022
Annual accounts 2022108,8 k €↓
2021
Annual accounts 2021218,5 k €↑
2018
Annual accounts 2018103,3 k €↓
2017
Annual accounts 2017118 k €↓
2016
Annual accounts 2016135,8 k €↑
2015
Annual accounts 2015131,7 k €↑
2014
Annual accounts 2014131,1 k €↓
2013
Annual accounts 2013149,2 k €↓
2012
Annual accounts 2012149,9 k €↑
2011
Annual accounts 2011133,7 k €↑
2010
Annual accounts 2010131,5 k €↑
2009
Annual accounts 2009118,2 k €↑
2008
Annual accounts 2008107,6 k €↑
2007
Annual accounts 200785,1 k €↑
2006
Annual accounts 200676,6 k €
15/11/2001
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

OOSTVELD - PHARMA

Overview

What does OOSTVELD - PHARMA do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline